Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Healthcare Online Network.

Altimmune Appoints Industry Veteran Christophe Arbet-Engels, M.D., PhD as Chief Medical Officer to Drive Next Phase of Clinical Development of Pemvidutide
Seasoned clinical leader to oversee Phase 3 development of pemvidutide in MASH Dr. Arbet-Engels has led late-stage development, regulatory approvals and commercial launches for multiple successful franchises GAITHERSBURG, Md., Sept. 29, 2025...

B.C. Doctor and Salem Pain Clinic Surrey Address Patients’ Sociologic Challenges, Per Research Data; Olumuyiwa Bamgbade
The Salem Anaesthesia Pain Clinic in Surrey BC Canada, Mitigates Sociomedical Problems of Chronic Pain Patients; Olumuyiwa Bamgbade SURREY, BC, CANADA, September 29, 2025 /EINPresswire.com/ -- Chronic pain is recognized as a clinical challenge....

SeaStar Medical Reports Positive Early Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) at the 5th International Symposium on Acute Kidney Injury in Children
Data show results consistent with clinical trial experience A high level of safety – no device-related adverse events Strong survival data extending to 90 days DENVER, Sept. 29, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq:...

Vor Bio Announces Late-Breaking Poster Presentation of Phase 3 Primary Sjögren’s Disease Clinical Study at ACR Convergence 2025
BOSTON, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that clinical data from the Phase 3 study in China evaluating telitacicept...

KALA BIO Announces Topline Results from CHASE Phase 2b Clinical Trial Evaluating KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED) Did Not Meet Primary Endpoint
-- Study did not meet primary endpoint of complete healing of PCED at Week 8; secondary endpoints also did not achieve statistical significance -- -- KPI-012 was well-tolerated with no treatment-related serious adverse events observed -- -- KALA...

Special Investigating Unit releases interim report on Tembisa Hospital investigation
#Tembisahospitalcapture: How two billion meant for healthcare was stolen The Special Investigating Unit (SIU) can reveal that there is a devastating plunder of the public purse, which we found in our probe into Tembisa Hospital, uncovering three...

Apyx Medical to Host Virtual Key Opinion Leader Event to Discuss the Commercial Launch of The AYON Body Contouring System™ on October 14, 2025
CLEARWATER, Fla., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion® and the AYON...

Halberd Corporation Acquires NeuroSense AI Corp., a Revolutionary Behavioral Intelligence Platform to Transform TBI, Other Research, and Clinical Assessment
JACKSON CENTER, Pa., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Halberd Corporation (OTC: HALB) today announced its acquisition of NeuroSense AI Corp., a groundbreaking artificial intelligence platform that will revolutionize behavioral analysis for...

Revolution Medicines Announces Key Leadership Additions, including Alan Sandler, M.D. as Chief Development Officer
REDWOOD CITY, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced the appointment of...

Candel Therapeutics Presents Phase 3 Clinical Trial of CAN-2409 in Localized Prostate Cancer at ASTRO 2025
CAN-2409 improved disease-free survival in patients with intermediate-to-high-risk, localized prostate cancer compared to placebo in patients treated with either conventional or moderate hypofractionated radiotherapy with curative intent,...

John Snow Labs’ Medical LLMs Now Available in Microsoft Azure Marketplace
LEWES, Del., Sept. 29, 2025 (GLOBE NEWSWIRE) -- John Snow Labs, the AI for healthcare company, today announced the availability of its Medical Large Language Models (LLMs) offer in the Microsoft Azure Marketplace, an online store providing...

CorMedix Announces Completion of Enrollment in Phase III ReSPECT Clinical Trial for REZZAYO
- Enrollment Completed in Ongoing Phase III ReSPECT Study in Prophylaxis of Fungal Infections in Adult Patients Undergoing Allogeneic Blood and Marrow Transplant - - Topline Results from ReSPECT Study Expected in 2Q 2026 - BERKELEY HEIGHTS, N.J.,...

CareCloud Announces Acquisition of HFMA’s MAP App to Expand AI-Driven Benchmarking in Hospitals and Integrated Health Systems
Acquisition and long-term partnership with HFMA further strengthen CareCloud’s position in the inpatient healthcare IT market SOMERSET, N.J., Sept. 29, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ: CCLD, CCLDO) (“CareCloud” or the “Company”),...

Liquidia to Present Clinical Data from ASCENT Trial at the CHEST 2025 Annual Meeting
MORRISVILLE, N.C., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary diseases, announced today the company will present two...

Autonomix Medical, Inc. Initiates Good Laboratory Practice (GLP) Study for Sensing and RF Ablation System
GLP study marks a key milestone in Autonomix's path to achieve regulatory approvals Company remains on track to submit Investigational Device Exemption (“IDE”), and if approved, commence U.S. clinical trials in 2026 to support a De Novo FDA...

E20 Adaptive Designs for Clinical Trials
Docket Number: FDA-2025-D-3023 Issued by: Guidance Issuing Office Center for Biologics Evaluation and Research Center for Drug Evaluation and Research The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft...

Multi-Hyphenate Creative Dana Abraham and Grain & Grit Beer Co. Bring Community Together for Lifesaving Medical Aid
A doc-drama themed halloween fundraiser in Hamilton, blending community, culture & compassion to support Doctors Without Borders in Gaza. HAMILTON, CANADA, September 29, 2025 /EINPresswire.com/ -- Bengali-Canadian actor, writer, and producer...

Eylsia Nicolas Claims #1 Spot on Groover Global Charts After Major Medical Setback
PALM BEACH, FL, UNITED STATES, September 29, 2025 /EINPresswire.com/ -- Eylsia Nicolas, a rising star in the music industry, that just claimed her place at the top of the Groover global charts as the number one singer-songwriter, as well as nine...

MannKind Appoints Dr. Ajay Ahuja as Executive Vice President and Chief Medical Officer
WESTLAKE VILLAGE, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative inhaled therapeutic products and devices for patients with endocrine and...
Macao Union Medical Center officially opens PUMCH Centennial Exhibition on Culture and Medical Records
MACAU, September 29 - The Islands Healthcare Complex – Macao Medical Center of Peking Union Medical College Hospital (hereinafter referred to as “Macao Union Medical Center”) held one of its series of anniversary events on 21 September. The event,...